Skip to main content
CHOLESTEROL, TRIGLYCERIDES & STATINS

Is a Statin Safe to Take With Metformin?

The two tablets don't interfere with each other — but they do share side effects, and that is where the real confusion starts.

5 min read
Photograph of two blister strips of tablets and loose round tablets scattered on a dark surface
Photo via padrinan / Pixabay (opens in a new tab)

Most people managing Type 2 diabetes in Pakistan end up holding two tablets at once: metformin, which has usually been there since the diagnosis, and a statin — atorvastatin or rosuvastatin — added later for heart protection. Nobody explains how the two get along, so the question arrives on its own somewhere around week two. Is it safe to swallow both?

Yes. And the reason is worth knowing, because it also explains what the two tablets can actually do to each other — which is a different and more useful question.

They leave your body by completely different doors

Drug interactions usually happen when two medicines compete for the same processing machinery. Metformin and statins never meet there. Metformin is barely metabolised at all — it is absorbed in the small intestine and leaves unchanged through the kidneys. Atorvastatin goes the other way entirely: the liver breaks it down using the CYP3A4 enzyme system, which is why grapefruit and certain antibiotics matter for statins and are irrelevant to metformin.

This has been measured directly rather than assumed. In a multiple-dose study of atorvastatin taken with metformin (opens in a new tab), researchers compared blood levels of each drug alone against blood levels when both were taken together. Atorvastatin exposure changed by about 5%, metformin by about 1% — well inside the range regulators treat as no change at all.

No clinically relevant pharmacokinetic interaction was seen when atorvastatin was co-administered with metformin.

The clinical version of that question has also been tested. The ATOMIC trial (opens in a new tab) randomised 185 people with Type 2 diabetes and dyslipidaemia to metformin alone, atorvastatin 40 mg alone, or both together for 16 weeks. Side effects in the combination group were the familiar ones — mostly mild stomach symptoms — with no significant excess over either drug on its own.

One result from that trial is worth pausing on. Statins nudge blood sugar upward, which is the single most common worry about adding one. In ATOMIC, HbA1c rose by 0.35% in the atorvastatin-only group — and fell by 0.35% in the group taking atorvastatin with metformin. Metformin comfortably absorbed the statin's glycaemic push. If you are already on metformin, you are already carrying the counterweight.

The actual problem: three symptoms both tablets can claim

So the tablets don't fight. What they do is share a symptom list, and when you feel unwell it becomes genuinely hard to know which one to blame — or whether to blame either. This is where people quietly stop the wrong medicine.

What you're feelingUsually points toReasonable next step
Nausea, loose stools, stomach ache — starting when the drug started, easing over 2–3 weeksMetformin, especially at a new or raised doseTake it mid-meal rather than before; ask about the extended-release form if it doesn't settle
Aching, tender or weak muscles — thighs, shoulders, both sidesThe statin, though far less often than assumedReport it; a different statin or a lower dose usually solves it. Don't just stop
Tingling, pins and needles, numbness in hands or feet; unusual tirednessNot the statin — this pattern fits vitamin B12 deficiency, which long-term metformin can causeAsk for a B12 level before anyone blames the statin

That third row is the one that gets missed, and it matters more in Pakistan than the international guidance suggests. In a case-control study at a hospital in Kharian, 31% of patients taking metformin were B12 deficient compared with 8.6% of those who weren't (opens in a new tab) — and duration mattered sharply: people on metformin longer than 24 months averaged a B12 level of 188 pg/ml against 414 pg/ml for those on it under 24 months.

The American Diabetes Association's Standards of Care (opens in a new tab) now advises considering periodic vitamin B12 testing for anyone on long-term metformin, particularly with anaemia or nerve symptoms. It is an inexpensive test, and it is the right one to run before concluding that a statin is causing your leg symptoms. Muscles that ache are a statin question; feet that tingle are usually not.

Warning: Muscle pain with a specific set of companions

Metformin's rare serious reaction, lactic acidosis, also includes muscle pain — but it never travels alone. MedlinePlus lists it alongside (opens in a new tab) deep or rapid breathing, severe weakness, vomiting, dizziness and feeling cold in the hands and feet. That combination is a same-day medical visit, not a phone call. Isolated aching muscles with no other symptoms is not this — the reaction occurs in roughly 3 to 10 people per 100,000 patient-years.

What actually changes when you're on both

Very little, practically speaking. There is no special timing rule for taking them together, no dose adjustment either way, and no extra blood test created by the combination itself. Your kidney function still gets checked because of metformin, and your lipid profile still gets checked because of the statin — the same two things that would be monitored if you were taking only one of them.

The one habit worth building is writing things down. If a symptom starts, the single most useful piece of information for your doctor is when it began relative to which tablet changed — and that detail is almost impossible to reconstruct from memory three weeks later.

Keep a record of what you're taking and when

Logging both tablets alongside your readings and any symptoms in Diatic gives your doctor something concrete to work from — so a side effect gets traced to the right medicine instead of guessed at.

Start logging with Diatic (opens Diatic on Google Play in a new tab)

Frequently asked questions

Is there a single tablet that combines a statin and metformin?

Fixed-dose atorvastatin/metformin combinations have been developed and studied, and they behave the same as the two separate tablets. Availability varies, so ask your pharmacist what is actually stocked locally rather than assuming — and never switch formulations without your doctor confirming the doses match.

Does adding a statin increase my risk of a hypo?

No. Statins don't lower blood sugar, and metformin on its own rarely causes hypoglycaemia because it doesn't force your pancreas to release extra insulin. If you are having lows, the cause is more likely a sulfonylurea or insulin in your regimen, or a missed meal — worth raising with your doctor either way.

Should I take them at the same time of day?

You can, and many people do for simplicity, but the two have different natural timings. Metformin is taken with meals to reduce stomach upset. Some statins — simvastatin in particular — are taken in the evening, while atorvastatin and rosuvastatin work at any consistent hour. Follow the instruction on each box; taking them in the same swallow causes no problem.

If I need to stop one of them, which is safer to pause?

Neither, on your own. Both are prescribed for problems you cannot feel, so stopping either quietly removes protection without producing any warning sign. Bring the side effect to your doctor instead — for statins in particular, switching to a different one or a lower dose resolves the issue far more often than stopping does.

Sources

  1. American Diabetes Association (ADA) — Standards of Care in Diabetes 2025, Section 10: Cardiovascular Disease and Risk Management (opens in a new tab)
  2. Endotext (NCBI Bookshelf, NIH) — Dyslipidemia in Patients with Diabetes (opens in a new tab)
  3. MedlinePlus (U.S. National Library of Medicine) — Cholesterol testing and results (opens in a new tab)
  4. Pakistan Journal of Medical Sciences — Frequency and pattern of dyslipidemia and its association with other risk factors among Type-2 Diabetics (opens in a new tab)
  5. Cholesterol Treatment Trialists' (CTT) Collaboration — Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia: an individual participant data meta-analysis (The Lancet Diabetes & Endocrinology, 2024) (opens in a new tab)
  6. NHS (UK) — Statins (opens in a new tab)
  7. SAMSON trial — N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects (New England Journal of Medicine, 2020) (opens in a new tab)
  8. MedlinePlus (U.S. National Library of Medicine) — Atorvastatin (opens in a new tab)
  9. MedlinePlus (U.S. National Library of Medicine) — Simvastatin (opens in a new tab)
  10. StatPearls (NCBI Bookshelf, NIH) — Dietary Therapy for LDL Cholesterol Reduction: Evidence-Based Patterns for Cardiovascular Risk Management (opens in a new tab)
  11. StatPearls (NCBI Bookshelf, NIH) — Statin Medications (opens in a new tab)
  12. Jovanovski et al. — Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials (The American Journal of Clinical Nutrition, 2018) (opens in a new tab)
  13. The Endocrine Society — Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (Journal of Clinical Endocrinology & Metabolism, 2012) (opens in a new tab)
  14. Journal of Clinical Lipidology (2025) — Trends and prevalence of severe hypertriglyceridemia in Pakistan: A 5-year analysis (2019–2023) (opens in a new tab)
  15. Cureus (2017) — Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus (opens in a new tab)
  16. American Diabetes Association (ADA) — Standards of Care in Diabetes 2026, Section 10: Cardiovascular Disease and Risk Management (opens in a new tab)
  17. Drug Design, Development and Therapy (2019) — Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets (opens in a new tab)
  18. Diabetes & Metabolism Journal — Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial (opens in a new tab)
  19. American Diabetes Association (ADA) — Standards of Care in Diabetes 2026, Section 3: Prevention or Delay of Diabetes and Associated Comorbidities (opens in a new tab)
  20. Pan African Medical Journal (2013) — Prevalence of Vitamin B12 deficiency in patients of type 2 diabetes mellitus on metformin: a case control study from Pakistan (opens in a new tab)
  21. MedlinePlus (U.S. National Library of Medicine) — Metformin (opens in a new tab)
  22. NHS (UK) — Metformin (opens in a new tab)
  23. World Journal of Diabetes — Metformin-associated lactic acidosis: A mini review of pathophysiology, diagnosis and management in critically ill patients (opens in a new tab)

Related reading